Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Allentown
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Allentown, PA

Studies commonly pay $75 to $4,500 per completed study

230 clinical trials are currently recruiting participants within 30 miles of Allentown. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

230studies recruiting
7+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Allentown right now

Top 25 of 230 recruiting studies, sorted by proximity — each links to its official registry page

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Acute Leukemia, Newly Diagnosed N/A Observational 1,365 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi) · Sponsor: Memorial Sloan Kettering Cancer Center

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Bethlehem, Pennsylvania (5.9 mi) · Sponsor: TG Therapeutics, Inc.

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
St. Luke's University Health Network ( Site 0017) — Bethlehem, Pennsylvania (5.9 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease Phase 2 Interventional 240 participants sought
Site Number - 1043 — Pottstown, Pennsylvania (25.9 mi) · Sponsor: Immunovant Sciences GmbH

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive Phase 3 Interventional 450 participants sought
Alliance Cancer Specialists — Sellersville, Pennsylvania (19.0 mi) · Sponsor: Nuvalent Inc.

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease Phase 2 Interventional 240 participants sought
Northeast Clinical Research Center — Bethlehem, Pennsylvania (5.9 mi) · Sponsor: Calico Life Sciences LLC

Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention

Suicide and Depression, Adolescent Behavior N/A Interventional 900 participants sought
Berks Community Health Center — Reading, Pennsylvania (29.8 mi) · Sponsor: University of Pittsburgh

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
St. Luke's University Health Network — Easton, Pennsylvania (14.8 mi) · Sponsor: Regeneron Pharmaceuticals

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Allentown, Pennsylvania (1.1 mi) · Sponsor: Medtronic

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 335 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.

Arthritis, Unstable Radial Head N/A Interventional 84 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi) · Sponsor: Aptis Medical

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 2 Interventional 60 participants sought
Investigator Site #30 — Bethlehem, Pennsylvania (5.9 mi) · Sponsor: Akebia Therapeutics

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Mid Atlantic Retina (Site 050) — Bethlehem, Pennsylvania (5.9 mi) · Sponsor: EyeBiotech Ltd.

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Lehigh Valley Hospital - Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: American Society of Clinical Oncology

A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT

Port-wine Birthmarks, Port-Wine Stain Phase 2 Interventional 84 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi) · Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Endometrial Cancer, Endometrioid Adenocarcinoma N/A Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi) · Sponsor: Memorial Sloan Kettering Cancer Center

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: PedAL BCU, LLC

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Advanced Malignant Tumors Phase 1 Interventional 437 participants sought
Local Institution - 0020 — Allentown, Pennsylvania (1.1 mi) · Sponsor: Bristol-Myers Squibb

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Pancreatic Carcinoma, Pancreatic Neoplasm Phase 3 Interventional 274 participants sought
Saint Luke's Cancer Center - Allentown — Allentown, Pennsylvania (1.1 mi) · Sponsor: SWOG Cancer Research Network
Actively enrolling

Studies you may be able to join near Allentown

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Allentown

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Lehigh Center for Clinical Research

★ 5.0
1245 S Cedar Crest Blvd, Allentown, PA 18103
(610) 820-0342
"Staff was very friendly and explained information to me in great detail"
— Virgilio Baello, 5★

Northeast Clinical Research Center

2014 City Line Rd #103, Bethlehem, PA 18017
(610) 433-4100

Northeast Clinical Trials and Research Institute LLC

★ 4.2 (15 reviews)
3465 Nazareth Rd Suite 102, Easton, PA 18045
(833) 330-0930
"Excellent care and professionalism"
— Violeta Navarrete, 5★

Lehigh Valley Cancer Institute

★ 1.0
Salisbury Township, PA 18103
"I'm so disappointed in my Hemo Doctor didn't communicate with me about my chemo treatments it's been a nightmare dealing with the staff here so unhap…"
— Vanessa Rymer, 1★

Targeted Medical Education

2351 Woodland Dr #101, Allentown, PA 18103
(855) 882-9635

Spokenword Clinical Trials Inc.

3465 Nazareth Rd, Easton, PA 18045
(610) 697-9683

Clinical Research Center-Reading

2760 Century Blvd #3, Reading, PA 19610
(610) 375-2466

Clinical trials in Allentown: what's recruiting

The Allentown area currently has 230 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Allentown, the most active research areas are:

  • Cancer & Oncology16 studies
  • Liver & Kidney3 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Allentown, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Allentown

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Allentown participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Allentown safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Allentown, PA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Allentown?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Allentown.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Allentown typically complete one or two studies per year.

Paid clinical trials near Allentown

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of PA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts